Forian Revenue Jumps 56 Percent in Q2

Forian (NASDAQ:FORA), a healthcare and life sciences data analytics provider, reported better-than-expected Q2 2025 results (GAAP), released on August 13, 2025. The company posted GAAP revenue of $7.48 million, outperforming analyst GAAP revenue estimates of $7.17 million by 4.3%. Reported net income per share was $0.01 (GAAP), exactly matching consensus expectations and reversing a prior-year per-share loss (GAAP). Strategic contract renewals and the ongoing integration of the Kyber Data Science acquisition contributed to top-line growth. Alongside improved profitability and cash flow, this marks a milestone on Forian’s path to scale. Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report. Forian is a technology company that delivers advanced analytics, data products, and solutions to healthcare, life sciences, and financial services clients. Its products transform complex clinical and financial datasets into actionable insights, helping organizations understand patient journeys, therapeutic effectiveness, and healthcare economics.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool